03.17.25 -- AI In A Time Of Uncertainty: Key Strategies To Enable Flexibility

On the latest episode of Business of Biotech, Affinia Therapeutics CEO Rick Modi shares how his Kenyan upbringing shaped his resilience, his transition from pharma to biotech, and the cutting-edge gene therapy work at Affinia. Recorded live at JPM in San Francisco, this conversation dives into leadership, innovation, and upcoming clinical trials. Listen now and subscribe so you don't miss an episode!

Discover how mobile visits are transforming clinical trials by reducing barriers to participation, enhancing diversity, and bringing studies closer to patients and their communities.

A new wet lab incubator space is set to launch in 2025 to foster biotech innovation. Follow along to gain insight into the progress and how this facility will support startups.

By 2025 and beyond, AI, structured data, and real-world evidence will reshape the landscape, driving personalized medicine and more efficient processes. Here are eight key trends to watch.

Hear from a panel of industry experts including Sanofi, Bayer, and the Clinical Trials Transformation Initiative (CTTI) as they discuss the evolution of digital trials and share their experiences.

When it comes to furthering AAV's potential in the wider biopharmaceutical pipeline, partnering with a CDMO that can foment an optimal analytical and manufacturing strategy is crucial.